High-Throughput Expression and Purification of E. coli Proteins
Author Information
Author(s): Ergin Asgar, Konrad Büssow, Joachim Sieper, Andreas Thiel, Rainer Duchmann, Thomas Adam
Primary Institution: Universitätsmedizin Berlin, Charité
Hypothesis
Highly conserved E. coli proteins may be involved in abnormal T cell responses in Inflammatory Bowel Disease (IBD).
Conclusion
The study successfully developed a cost-efficient method to produce around 200 soluble recombinant E. coli proteins for immunological studies.
Supporting Evidence
- 73% of targeted proteins were expressed and purified in large-scale.
- 204 proteins (97.6%) could be purified from small-scale expression.
- High-throughput techniques were applied for cloning and purification.
Takeaway
The researchers figured out how to make a lot of important proteins from E. coli that could help us understand a disease called Inflammatory Bowel Disease.
Methodology
The study used PCR amplification, cloning into expression vectors, and high-throughput purification techniques to express and purify E. coli proteins.
Limitations
Some proteins could not be expressed or yielded low amounts, particularly those with transmembrane domains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website